Current Issue : October-December Volume : 2026 Issue Number : 4 Articles : 1 Articles
Globally, type 2 diabetes mellitus (T2DM) is a chronic metabolic disease that is spreading quickly and has significant clinical, financial and social costs. Medication non-adherence, drug-related problems (DRPs), adverse drug responses, polypharmacy and complex therapy regimens make it difficult to achieve adequate glycemic control even with the availability of effective pharmacological interventions. These difficulties often impair the efficacy of treatment, raise healthcare costs and hasten the onset of problems associated with diabetes. With active pharmacist involvement, pharmaceutical care has become a patient-centered practice approach that aims to maximize medication use and enhance therapeutic results. With a focus on medication adherence, DRP detection and resolution and their effects on patient outcomes, this study examines the role of pharmacological treatment in the management of type 2 diabetes. The pathophysiological basis of type 2 diabetes, traditional and modern antidiabetic treatments, factors that contribute to medication non-adherence, techniques for evaluating adherence and the clinical and financial ramifications of poor adherence are all covered in this study. Adverse drug responses, drug-drug interactions, polypharmacy, improper prescribing and medication errors are among the common DRPs that are further examined. Furthermore, a critical evaluation is conducted of pharmacist-led interventions, including pharmaceutical therapy management, patient education, therapeutic counselling, assistance for lifestyle modification, collaborative healthcare practice and telepharmacy. According to available data, pharmaceutical care interventions lower avoidable complications and healthcare utilization while improving medication adherence, glycemic control, drug safety, patient satisfaction and health-related quality of life. Precision pharmacotherapy, artificial intelligence, digital therapies and remote monitoring technologies are examples of emerging developments that present intriguing prospects to improve diabetes care. All things considered, pharmaceutical care continues to be a crucial part of all-encompassing T2DM management and greatly enhances clinical, humanistic and economic outcomes globally....
Loading....